<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Maspa Lapui</style></author><author><style face="normal" font="default" size="100%">Wahiduddin</style></author><author><style face="normal" font="default" size="100%">Ida Leida Maria</style></author><author><style face="normal" font="default" size="100%">A Arsunan Arsin</style></author><author><style face="normal" font="default" size="100%">Ridwan M Thaha</style></author><author><style face="normal" font="default" size="100%">Syamsuar Manyullei</style></author><author><style face="normal" font="default" size="100%">Anwar Mallongi</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">The Effectiveness of SI-DINI Mobile App (an Education and Early Detection of Leprosy App) on Changes in Community Behavior</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Attitude</style></keyword><keyword><style  face="normal" font="default" size="100%">Behavior.</style></keyword><keyword><style  face="normal" font="default" size="100%">knowledge</style></keyword><keyword><style  face="normal" font="default" size="100%">Leprosy</style></keyword><keyword><style  face="normal" font="default" size="100%">SI-DINI App</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2023</style></year><pub-dates><date><style  face="normal" font="default" size="100%">October 2023</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">15</style></volume><pages><style face="normal" font="default" size="100%">868-872</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;Most leprosy case detection in Indonesia is based on passive surveillance. This condition impacts the high number of new cases of leprosy and the disability rate of leprosy. Data from the Ministry of Health of the Republic of Indonesia stated that for 2021, there were 7,201 new cases of leprosy with a disability proportion of 84.6%. The community's reluctance to make early contact is due to low knowledge and fear of stigma. SI-DINI is an android-based application that contains information about leprosy, videos on identifying the characteristics and symptoms of leprosy, and reporting suspected leprosy so that it is hoped that it can change people's behavior in a positive direction. This study aims to see the effectiveness of the SI-DINI App in changing people's behavior. This study used a quasi-experimental design with a pre and post-test design with intervention and control groups. The use of the SI-DINI App has been proven effective in changing people's behavior in terms of knowledge, attitudes and actions. There is a significant increase in the knowledge aspect with&lt;em&gt; p&lt;/em&gt;-value = 0.000 (&lt;em&gt;p&lt;/em&gt;&amp;lt;0,05), the attitude aspect&lt;em&gt; p&lt;/em&gt;-value = 0.000 (&lt;em&gt;p&lt;/em&gt;&amp;lt;0,05), and the action aspect p-value = 0.000 (&lt;em&gt;p&lt;/em&gt;&amp;lt;0,05). It is hoped that the application of education and surveillance for early detection of leprosy (SI-DINI) can be applied on a broader scope and can be used sustainably and in the future.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">5</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">868</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Maspa Lapui&lt;sup&gt;1,*&lt;/sup&gt;, Wahiduddin&lt;sup&gt;1&lt;/sup&gt;, Ida Leida Maria&lt;sup&gt;1&lt;/sup&gt;, A Arsunan Arsin&lt;sup&gt;1&lt;/sup&gt;, Ridwan M Thaha&lt;sup&gt;2&lt;/sup&gt;, Syamsuar Manyullei&lt;sup&gt;3&lt;/sup&gt;, Anwar Mallongi&lt;sup&gt;3&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Epidemiology, Faculty of Public Health, Hasanuddin University, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Health Promotion and Behavioral Sciences, Faculty of Public Health, Hasanuddin University, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Department of Environmental Health, Faculty of Public Health, Hasanuddin University, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Ditya Indrawati</style></author><author><style face="normal" font="default" size="100%">Linda Astari</style></author><author><style face="normal" font="default" size="100%">Afif Nurul Hidayati</style></author><author><style face="normal" font="default" size="100%">Sawitri, Damayanti</style></author><author><style face="normal" font="default" size="100%">Budi Utomo</style></author><author><style face="normal" font="default" size="100%">Bagus Haryo Kusumaputra</style></author><author><style face="normal" font="default" size="100%">Medhi Denisa Alinda</style></author><author><style face="normal" font="default" size="100%">Cita Rosita Sigit Prakoeswa</style></author><author><style face="normal" font="default" size="100%">M. Yulianto Listiawan</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Risk Factors of Acute and Chronic Erythema Nodosum Leprosum in Dr. Soetomo General Academic Hospital Surabaya</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Acute ENL</style></keyword><keyword><style  face="normal" font="default" size="100%">Chronic ENL</style></keyword><keyword><style  face="normal" font="default" size="100%">ENL</style></keyword><keyword><style  face="normal" font="default" size="100%">Leprosy</style></keyword><keyword><style  face="normal" font="default" size="100%">Neglected disease.</style></keyword><keyword><style  face="normal" font="default" size="100%">Risk factors</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2022</style></year><pub-dates><date><style  face="normal" font="default" size="100%">December 2022</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">14</style></volume><pages><style face="normal" font="default" size="100%">766-770</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt; Leprosy is a chronic granulomatous infection and is one of the neglected diseases caused by &lt;em&gt;Mycobacterium leprae.&lt;/em&gt; ENL is a complex syndrome, that caused inflammation of the skin, nerves, and other organs due to an inflammatory immune response to &lt;em&gt;Mycobacterium leprae &lt;/em&gt;antigens. Acute ENL was defined as the first episode of ENL with a duration of less than 24 weeks. Chronic ENL was defined as ENL that persisted for more than 24 weeks. These types of ENL can have different risk factors and require different therapeutic interventions. Purpose: The onset of ENL is acute, but may progress to a chronic or recurrent phase and require long-term therapy. Early detection of leprosy is very important, because the infection is curable and prompt treatment can reduce nerve damage and associated stigma. Chronic ENL patients require prolonged high doses of corticosteroids to control inflammation in ENL and cause severe complications and side effects associated with morbidity and mortality.&lt;strong&gt; Methods: &lt;/strong&gt;This retrospective study was conducted using a non-probability sampling technique consecutively using a casecontrol formula in leprosy patients with ENL in the Leprosy Division of the Outpatient Dermatology and Venereology Unit RSUD Dr. Soetomo Surabaya for the period 2015 – 2020, using secondary data in the form of medical record data.&lt;strong&gt; Result: &lt;/strong&gt;The results of this study obtained leprosy patients with ENL as many as 234 patients, 56 patients with acute ENL and 89 patients with chronic ENL. 45 patients with acute ENL and 45 patients with chronic ENL were obtained from the case-control minimal sample size formula. &lt;strong&gt;Conclusion:&lt;/strong&gt; The results of the bivariate analysis test showed that there was a relationship between risk factors for coinfection and steroid therapy with the type of ENL. The presence of coinfection and steroid therapy showed that patients tend to be chronic ENL, conversely, in the absence of coinfection and without steroid therapy, patients tend to be acute ENL. The multivariate logistic regression analysis test showed a significant association between risk factors for ENL onset before MDT and the presence of coinfection with chronic ENL, whereas ENL onset after MDT and absence of coinfection were associated with acute ENL.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">6</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">766</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Ditya Indrawati, Linda Astari, Afif Nurul Hidayati, Sawitri, Damayanti, Budi Utomo, Bagus Haryo Kusumaputra, Medhi Denisa Alinda, Cita Rosita Sigit Prakoeswa, M. Yulianto Listiawan*&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;Resident of Dermatology and Venereology, Faculty of Medicine, Universitas Airlangga/ Dr. Soetomo General Academic Hospital, Surabaya, INDONESIA.&lt;/p&gt;
</style></auth-address></record></records></xml>